{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T21:50:07Z","timestamp":1782337807971,"version":"3.54.5"},"reference-count":38,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cannabis &amp; Cannabinoid Research"],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>The purpose of this pilot study was to investigate cannabidiol (CBD) cream\u2019s effects on muscle soreness and performance after exercise.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      This double-blinded, placebo-controlled experiment included 15 men and 13 women (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 28; mean \u00b1 standard deviation age: 23.29 \u00b1 2.54 years) untrained in lower-body resistance training. Participants were randomized into control (NG,\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 9), CBD (CG,\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 9), or placebo (PG,\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 10) groups. Participants completed a lower-body fatigue protocol (FP) consisting of unilateral maximal concentric and eccentric isokinetic muscle actions of the quadriceps and hamstrings (5 sets, 10 repetitions, both legs). CG and PG participants applied \u223c100 mg CBD or placebo cream, respectively, matched for weight and appearance to the quadriceps on three separate days. NG participants engaged in a sitting rest period matched in duration to cream application processes. Questionnaires, pressure\u2013pain threshold (PPT), peak torque test (PTT), and countermovement jump (CMJ) were assessed. Mixed-model analysis of variance was conducted to assess main effects and interactions (group \u00d7 muscle \u00d7 time; group \u00d7 time).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      There were no significant interactions or main effects for group for PPT, CMJ, or PTT. There were main effects for time (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.05) for all soreness questions, PPT, CMJ, and PTT. There was one significant interaction (group \u00d7 time;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.045) for cream\/rest effect questions, in which PG participants perceived the effect of cream to be greater than the effect of rest for NG participants. There were main effects for group (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2264 0.031) for all soreness questions, in which PG participants perceived enhanced recovery.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The present pilot study did not discover any significant impacts of CBD cream use for muscle recovery. For individuals seeking to attenuate muscle soreness and improve performance, the current dose of this topical CBD product may not be an effective treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/can.2024.0012","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T12:45:42Z","timestamp":1720529142000},"page":"445-456","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["Topical Cannabidiol Application May Not Attenuate Muscle Soreness or Improve Performance: A Randomized, Double-Blinded, Placebo-Controlled Pilot Study"],"prefix":"10.1177","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0677-7259","authenticated-orcid":false,"given":"Joseph T.","family":"Pastina","sequence":"first","affiliation":[{"name":"Department of Kinesiology &amp; Health Promotion, The University of Kentucky, Lexington, Kentucky, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G.","family":"Abel","sequence":"additional","affiliation":[{"name":"Department of Kinesiology &amp; Health Promotion, The University of Kentucky, Lexington, Kentucky, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance M.","family":"Bollinger","sequence":"additional","affiliation":[{"name":"Department of Kinesiology &amp; Health Promotion, The University of Kentucky, Lexington, Kentucky, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart A.","family":"Best","sequence":"additional","affiliation":[{"name":"Department of Kinesiology &amp; Health Promotion, The University of Kentucky, Lexington, Kentucky, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"publisher","DOI":"10.2165\/00007256-200838060-00004"},{"key":"e_1_3_6_3_2","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00971.2016"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.4085\/1062-6050-50.1.01"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.1123\/jsr.5.3.234"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.13853"},{"key":"e_1_3_6_7_2","doi-asserted-by":"publisher","DOI":"10.1123\/ijsnem.2020-0151"},{"key":"e_1_3_6_8_2","doi-asserted-by":"publisher","DOI":"10.1186\/s42238-021-00061-5"},{"key":"e_1_3_6_9_2","doi-asserted-by":"publisher","DOI":"10.1089\/can.2018.0006"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19030833"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-45541-9"},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14038"},{"key":"e_1_3_6_13_2","doi-asserted-by":"publisher","DOI":"10.1249\/MSS.0000000000002606"},{"issue":"6","key":"e_1_3_6_14_2","article-title":"Acute supplementation with cannabidiol does not attenuate inflammation or improve measures of performance following strenuous exercise","volume":"10","author":"Crossland BW","year":"2022","unstructured":"Crossland BW, , Rigby BR, , Duplanty AA, et al. Acute supplementation with cannabidiol does not attenuate inflammation or improve measures of performance following strenuous exercise. Healthcare (Basel), 2022; 10(6); doi: 10.3390\/healthcare10061133","journal-title":"Healthcare (Basel)"},{"key":"e_1_3_6_15_2","first-page":"89","article-title":"The influence cannabidiol on delayed onset of muscle soreness","volume":"7","author":"Hatchett A","year":"2020","unstructured":"Hatchett A, , Armstrong K, , Hughes B, et al. The influence cannabidiol on delayed onset of muscle soreness. International Journal of Physical Education, Sports and Health, 2020; 7:89\u201394.","journal-title":"International Journal of Physical Education, Sports and Health"},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40798-022-00417-y"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu15122664"},{"key":"e_1_3_6_18_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu13093028"},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.2196\/34132"},{"key":"e_1_3_6_20_2","doi-asserted-by":"publisher","DOI":"10.1186\/s42238-023-00179-8"},{"key":"e_1_3_6_21_2","doi-asserted-by":"publisher","DOI":"10.1089\/can.2022.0220"},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.1089\/can.2021.0154"},{"issue":"3","key":"e_1_3_6_23_2","first-page":"1426","article-title":"Topical cannabidiol and the progression rate of delayed onset muscle soreness","volume":"16","author":"Alpy A","year":"2023","unstructured":"Alpy A, , Yusuff G, , Simpson T, et al. Topical cannabidiol and the progression rate of delayed onset muscle soreness. Int J Exerc Sci, 2023; 16(3):1426\u20131439.","journal-title":"Int J Exerc Sci"},{"key":"e_1_3_6_24_2","doi-asserted-by":"publisher","DOI":"10.2174\/1389201020666191202111534"},{"key":"e_1_3_6_25_2","unstructured":"What You Should Know About Using Cannabis Including CBD When Pregnant or Breastfeeding. U.S. Food & Drug Administration; 2019. Available from: https:\/\/www.fda.gov\/consumers\/consumer-updates\/what-you-should-know-about-using-cannabis-including-cbd-when-pregnant-or-breastfeeding"},{"key":"e_1_3_6_26_2","doi-asserted-by":"publisher","DOI":"10.1249\/00005768-199512000-00017"},{"key":"e_1_3_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(87)90089-3"},{"key":"e_1_3_6_28_2","doi-asserted-by":"publisher","DOI":"10.1519\/JSC.0000000000002160"},{"key":"e_1_3_6_29_2","doi-asserted-by":"publisher","DOI":"10.2165\/00007256-200434010-00005"},{"key":"e_1_3_6_30_2","unstructured":"Borg G. Borg\u2019s Perceived Exertion And Pain Scales. 1998."},{"key":"e_1_3_6_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/epi.16878"},{"key":"e_1_3_6_32_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2013.00863"},{"key":"e_1_3_6_33_2","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2020.1797808"},{"key":"e_1_3_6_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0b013e318154b6ae"},{"key":"e_1_3_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbmt.2017.06.006"},{"key":"e_1_3_6_36_2","doi-asserted-by":"publisher","DOI":"10.2165\/00007256-200333020-00005"},{"key":"e_1_3_6_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bkae001"},{"key":"e_1_3_6_38_2","doi-asserted-by":"publisher","DOI":"10.1590\/s1984-82502016000300018"},{"key":"e_1_3_6_39_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16020202"}],"container-title":["Cannabis &amp; Cannabinoid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/can.2024.0012","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/can.2024.0012","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/can.2024.0012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:13:54Z","timestamp":1777385634000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/can.2024.0012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6,1]]}},"alternative-id":["10.1089\/can.2024.0012"],"URL":"https:\/\/doi.org\/10.1089\/can.2024.0012","relation":{},"ISSN":["2578-5125","2378-8763"],"issn-type":[{"value":"2578-5125","type":"print"},{"value":"2378-8763","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]}}}